tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APLS Stock Latest News

Empaveli’s Promising Efficacy and Market Position Boosts Buy Rating
RatingsEmpaveli’s Promising Efficacy and Market Position Boosts Buy Rating
18h ago
APLS
Apellis price target raised to $29 from $26 at BofA
PremiumThe Fly
Apellis price target raised to $29 from $26 at BofA
22h ago
APLS
Apellis announces new data from Phase 3 VALIANT study on EMPAVELI
PremiumThe Fly
Apellis announces new data from Phase 3 VALIANT study on EMPAVELI
22h ago
APLS
Hold Rating for Apellis Pharmaceuticals Amid Limited Growth Potential and Market Challenges
PremiumRatings
Hold Rating for Apellis Pharmaceuticals Amid Limited Growth Potential and Market Challenges
23h ago
APLS
Apellis upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Apellis upgraded to Overweight from Equal Weight at Wells Fargo
6d ago
APLS
Cautious Outlook on Apellis Pharmaceuticals Amid Market Challenges and Financial Constraints
PremiumRatingsCautious Outlook on Apellis Pharmaceuticals Amid Market Challenges and Financial Constraints
22d ago
APLS
Buy Rating for Apellis Pharmaceuticals: Long-Term Growth Potential Amidst Current Challenges
Premium
Ratings
Buy Rating for Apellis Pharmaceuticals: Long-Term Growth Potential Amidst Current Challenges
22d ago
APLS
Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
Premium
The Fly
Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
25d ago
W
HD
Morning Movers: Pharma, truck stocks react to Trump tariff announcements
PremiumThe Fly
Morning Movers: Pharma, truck stocks react to Trump tariff announcements
25d ago
W
LLY
Apellis downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
Apellis downgraded to Sell from Neutral at Goldman Sachs
25d ago
APLS
Short Report: Kohls, Krispy Kreme shorts cover as meme stock fever breaks
PremiumThe Fly
Short Report: Kohls, Krispy Kreme shorts cover as meme stock fever breaks
2M ago
KSS
PGY
Hold Rating for Apellis Pharmaceuticals’ Empaveli Amid Market Challenges and Physician Preferences
PremiumRatings
Hold Rating for Apellis Pharmaceuticals’ Empaveli Amid Market Challenges and Physician Preferences
3M ago
APLS
Apellis Pharmaceuticals’ Earnings Call: A Balanced Outlook
PremiumCompany AnnouncementsApellis Pharmaceuticals’ Earnings Call: A Balanced Outlook
3M ago
APLS
Apellis price target raised to $37 from $35 at JPMorgan
Premium
The Fly
Apellis price target raised to $37 from $35 at JPMorgan
3M ago
APLS
Apellis price target raised to $40 from $39 at Cantor Fitzgerald
Premium
The Fly
Apellis price target raised to $40 from $39 at Cantor Fitzgerald
3M ago
APLS
Apellis price target lowered to $50 from $52 at Raymond James
PremiumThe Fly
Apellis price target lowered to $50 from $52 at Raymond James
3M ago
APLS
Steady Growth and Future Potential: A Hold Rating for Apellis Pharmaceuticals
PremiumRatings
Steady Growth and Future Potential: A Hold Rating for Apellis Pharmaceuticals
3M ago
APLS
Cautious Outlook on Apellis Pharmaceuticals: Hold Rating Amidst Modest Syfovre Growth and Empaveli Expansion
PremiumRatings
Cautious Outlook on Apellis Pharmaceuticals: Hold Rating Amidst Modest Syfovre Growth and Empaveli Expansion
3M ago
APLS
Apellis price target raised to $52 from $46 at Citi
PremiumThe Fly
Apellis price target raised to $52 from $46 at Citi
3M ago
APLS
Apellis Pharmaceuticals Reports Q2 2025 Earnings
PremiumCompany AnnouncementsApellis Pharmaceuticals Reports Q2 2025 Earnings
3M ago
APLS
Apellis price target raised to $26 from $24 at Goldman Sachs
Premium
The Fly
Apellis price target raised to $26 from $24 at Goldman Sachs
3M ago
APLS
3 Best Stocks to Buy Now, 7/31/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/31/2025, According to Top Analysts
3M ago
GH
APLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >